<DOC>
	<DOCNO>NCT01415505</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability nebivolol valsartan give free tablet combination patient stage 1 stage 2 essential hypertension .</brief_summary>
	<brief_title>Combination Nebivolol Valsartan Given Free Tablets Stage 1 Stage 2 Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Male female outpatient age 18 year Patients diagnose stage 1 stage 2 essential hypertension Normal physical examination finding , electrocardiogram ( ECG ) result chest xray ; abnormal finding judge Investigator clinically significant Secondary hypertension severe hypertension Clinically significant cardiovascular disease heart failure A medical contraindication discontinue current antihypertensive therapy History Type 1 diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Stage 1</keyword>
	<keyword>Stage 2</keyword>
	<keyword>Hypertension</keyword>
	<keyword>1 year open label safety study</keyword>
</DOC>